Transplant Immunosuppression Posters

Tuesday July 03, 2018 from 16:30 to 17:30

Room: Hall 10 - Exhibition

P.266 Analysis of CCR4high CD4+ in kidney graft blood after steroid withdrawal: A prospective, randomized, controlled, parallel group study. Preliminary results

Teresa Vazquez, Spain

Resident doctor
Nephrology
Regional University Hospital of Malaga and University of Malaga, IBIMA, REDinREN (RD16/0009/0006)

Abstract

Analysis of CCR4high CD4+ in Kidney Graft Blood after Steroid Withdrawal: A Prospective, Randomized, Controlled, Parallel Group Study. Preliminary Results

Teresa Vazquez1, Abelardo Caballero2, Elisea Marques1, Pedro Ruiz Esteban1, Eulalia Palma1, Juana Alonso-Titos1, Veronica Lopez1, Eugenia Sola1, Mercedes Cabello1, Ana Duarte1, Cristina Jironda1, Domingo Hernandez1.

1Nephrology Department, Regional University Hospital of Malaga and University of Malaga, IBIMA, REDinREN (RD16/0009/0006), Malaga, Spain; 2Immunology Department, Regional University Hospital of Malaga and University of Malaga. IBIMA. REDINREN (RD16/0009/0006), Malaga, Spain

Introduction: Steroids represent a mainstay of immunosuppression after kidney transplant. The infiltration into the graft of active T cells following KT depends on the expression of chemokines and their interaction with their T-cell receptors. However, the natural history of the expression of these molecules in patients who undergo steroid withdrawal after transplant is unknown.
Materials and Methods: In a controlled clinical trial (NCT02284464), a total of 176 KT patients  with low immunological risk were recruited to randomly receive either conventional triple immunosuppression: steroids, TAC and MMF (Group A) versus steroid withdrawal at the 3 post-KT month (Group B). We compared the evolution of CCR4highCD4+ and CXCR3highCD4+ lymphocyte subpopulations in graft blood (GB) extracted by fine needle aspiration puncture determined by flow cytometry in patients after steroid withdrawal at the 3 month post-KT versus patients who continue to receive conventional triple immunosuppression. Measurements were made at 3 (baseline) and 6 months post-KT in GB and in peripheral blood (PB).
Results: So far, 68 patients have been randomized (34 in each group). There were no significant differences in the clinical and demographic characteristics between the groups at baseline. The first analysis (at 3 months) in those patients who had completed 6 months of follow-up (Group A: n=13; Group B: n=15) showed a significant increase in the CCR4highCD4 subpopulations in GB versus PB in both groups. However, at six months a significant increase in GB versus PB was only seen in Group A. There were no significant differences in the CXCR3highCD4+ lymphocyte subpopulation at the third or sixth month between GB and PB in either group (Table).
Conclusion: These preliminary results could suggest a possible effect of prednisone that would favor the recruitment of CCR4highCD4+ cells into the renal graft.

Evolution of CCR4highCD4+ and CXCR3highCD4+ lymphocyte subpopulations
  Group A Group B
  PB GB P PB GB P
CCR4highCD4+ (%)            
3 months 0.40±0.34 2.28±2.46 0.001 0.45±0.64 2.09±3.84 0.003
6 months 0.42±0.57 2.97±5.35 0.023 0.71±0.81 1.27±1.43 0.117
CXCR3highCD4+ (%)            
3 months 0.78±1.54 0.82±1.30 0.950 0.72±1.34 0.50±0.92 0.567
6 months 0.99±1.73 1.63±4.64 0.423 2.82±4.70 1.05±1.55 0.063

 

Spanish Ministry of Economy and Competitiveness (MINECO) (grant ICI14/00016) from the Instituto de Salud Carlos III co-funded by the Fondo Europeo de Desarrollo Regional–FEDER, RETICS (REDINREN RD12/0021/0015, RD16/0009/0006).



© 2024 TTS2018